bromocriptine for diabetes
Selected indexed studies
- Bromocriptine and Colesevelam Hydrochloride: Novel Therapies for Type II Diabetes Mellitus. (Cureus, 2023) [PMID:38192911]
- Bromocriptine for diabetes mellitus type II. (Cardiol Rev, 2011) [PMID:21983314]
- Bromocriptine mesylate for glycemic management in type 2 diabetes mellitus. (Ann Pharmacother, 2010) [PMID:20978217]
_Worker-drafted node — pending editorial review._
Connections
bromocriptine for diabetes is a side effect of
Sources
- Bromocriptine and Colesevelam Hydrochloride: Novel Therapies for Type II Diabetes Mellitus. (2023) pubmed
- Bromocriptine for diabetes mellitus type II. (2011) pubmed
- Bromocriptine mesylate for glycemic management in type 2 diabetes mellitus. (2010) pubmed
- Bromocriptine (Cycloset) for type 2 diabetes. (2010) pubmed
- Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes. (2011) pubmed
- Treatment of Prolactinoma. (2022) pubmed
- Diagnosis and Treatment of Pituitary Adenomas: A Review. (2017) pubmed
- Prolactinoma Management. (2000) pubmed
- Bromocriptine mesylate (Cycloset) for type 2 diabetes mellitus. (2013) pubmed
- Bromocriptine. (2012) pubmed